相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials
William C. Jackson et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Effect of Androgen Deprivation on Long-term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or Unfavorable A Secondary Analysis of the RTOG 9408 Randomized Clinical Trial
Zachary S. Zumsteg et al.
JAMA NETWORK OPEN (2020)
Active Surveillance for Low-Risk Prostate Cancer in Black Patients
Santino Butler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options
Martin G. Sanda et al.
JOURNAL OF UROLOGY (2018)
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
W. James Morris et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Evaluation of the effectiveness of adding androgen deprivation to modern dose-escalated radiotherapy for men with favorable intermediate-risk prostate cancer
Aaron D. Falchook et al.
CANCER (2016)
The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer
Mark Shilkrut et al.
CANCER (2013)
Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer
W. James Morris et al.
CANCER (2013)
A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation Therapy
Zachary S. Zumsteg et al.
EUROPEAN UROLOGY (2013)
Is Androgen Deprivation Therapy Necessary in All Intermediate-Risk Prostate Cancer Patients Treated in the Dose Escalation Era?
Katherine O. Castle et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Outcomes following iodine-125 prostate brachytherapy with or without neoadjuvant androgen deprivation
Toshio Ohashi et al.
RADIOTHERAPY AND ONCOLOGY (2013)
High-Dose Radiotherapy With or Without Androgen Deprivation Therapy for Intermediate-Risk Prostate Cancer: Cancer Control and Toxicity Outcomes
Scott Edelman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer
Peter J. Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial
James W. Denham et al.
LANCET ONCOLOGY (2011)
Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer
Christopher U. Jones et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31
Jason A. Efstathiou et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Interplay of Race, Socioeconomic Status, and Treatment on Survival of Patients With Prostate Cancer
Kendra Schwartz et al.
UROLOGY (2009)
Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02
Jason A. Efstathiou et al.
EUROPEAN UROLOGY (2008)
12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer (Reprinted from The Journal of Urology, vol 173, pg 1562-1566, 2005)
Louis Potters et al.
JOURNAL OF UROLOGY (2008)
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer
Christopher S. Saigal et al.
CANCER (2007)
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Nancy L. Keating et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate
JR Sathya et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial
HJ Green et al.
BJU INTERNATIONAL (2002)
The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma
FJ Fowler et al.
CANCER (2002)
分享论文
